Quarterly report [Sections 13 or 15(d)]

Unaudited Condensed Consolidated Balance Sheets

v3.25.1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2025
Jan. 31, 2025
Current assets:    
Cash and cash equivalents $ 127,841 $ 100,766
Restricted cash 3,091 2,571
Accounts receivable, net of allowance for credit losses of approximately $269 and $501 as of April 30, 2025 and January 31, 2025, respectively 95,988 178,989
Prepaid expenses and other current assets 50,917 50,527
Total current assets 277,837 332,853
Goodwill 317,071 317,071
Intangible assets, net 401,967 427,221
Other assets 25,611 28,924
Total assets 1,022,486 1,106,069
Current liabilities:    
Current maturities of long-term debt 6,404 6,404
Borrowings under accounts receivable facility 1,000 1,000
Accounts payable 20,789 13,458
Accrued Employee Benefits, Current 29,144 47,803
Accrued expenses and other current liabilities 23,790 26,022
Deferred revenue 243,788 282,295
Total current liabilities 324,915 376,982
Long-term debt 572,232 573,267
Deferred tax liabilities 41,042 42,039
Deferred revenue - non-current 1,170 1,656
Other long-term liabilities 20,478 18,279
Total long-term liabilities 634,922 635,241
Commitments and contingencies
Shareholders’ equity (deficit):    
Shareholders’ common stock - Class A common shares, $0.0001 par value: 18,750,000 shares authorized and 8,651,941 shares issued and 8,352,164 shares outstanding as of April 30, 2025, and 8,616,633 shares issued and 8,316,856 shares outstanding as of January 31, 2025 1 1
Additional paid-in capital 1,568,919 1,565,040
Accumulated (deficit) (1,481,435) (1,443,386)
Treasury stock, at cost - 299,777 as of April 30, 2025 and January 31, 2025 (10,891) (10,891)
Accumulated other comprehensive income (loss) (13,945) (16,918)
Total shareholders’ equity (deficit) 62,649 93,846
Total liabilities and shareholders’ equity (deficit) $ 1,022,486 $ 1,106,069